Evidence map›Paper›PMID 39728782›Full record

ArticleToxins2024

Bicistronic Vector Expression of Recombinant Jararhagin-C and Its Effects on Endothelial Cells.

Karla Fernanda Ferraz, Lhiri Hanna De Lucca Caetano, Daniele Pereira Orefice, Paula Andreia Lucas Calabria, Maisa Splendore Della-Casa, Luciana Aparecida Freitas-de-Sousa, Emidio Beraldo-Neto, Sabri Saeed Sanabani, Geraldo Santana Magalhães, Patricia Bianca Clissa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxins, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karla Fernanda FerrazImmunopathology Laboratory, Butantan Institute, São Paulo 05585-090, Brazil.
Lhiri Hanna De Lucca CaetanoImmunopathology Laboratory, Butantan Institute, São Paulo 05585-090, Brazil.ORCID 0000-0002-7388-5036
Daniele Pereira OreficeImmunopathology Laboratory, Butantan Institute, São Paulo 05585-090, Brazil.
Paula Andreia Lucas CalabriaImmunopathology Laboratory, Butantan Institute, São Paulo 05585-090, Brazil.ORCID 0000-0001-7955-4724
Maisa Splendore Della-CasaImmunopathology Laboratory, Butantan Institute, São Paulo 05585-090, Brazil.
Luciana Aparecida Freitas-de-SousaImmunopathology Laboratory, Butantan Institute, São Paulo 05585-090, Brazil.ORCID 0000-0002-4426-0731
Emidio Beraldo-NetoBiochemistry Laboratory, Butantan Institute, São Paulo 05503-900, Brazil.ORCID 0000-0002-4735-5162
Sabri Saeed SanabaniLaboratory of Medical Investigation LIM-56, Division of Dermatology, Medical School, University of São Paulo, Sao Paulo 05508-220, Brazil.ORCID 0000-0002-8876-8262
Geraldo Santana MagalhãesImmunopathology Laboratory, Butantan Institute, São Paulo 05585-090, Brazil.ORCID 0000-0003-4292-7827
Patricia Bianca ClissaImmunopathology Laboratory, Butantan Institute, São Paulo 05585-090, Brazil.

Funding

São Paulo Research Foundation (FAPESP) 2020/08863-1
6 · The paper itself

Abstract

Jararhagin-C (JarC) is a protein from the venom of

Indexed as

Human Umbilical Vein Endothelial CellsRecombinant ProteinsAnimalsBothropsBothrops jararaca VenomCell MovementCrotalid VenomsDisintegrinsGenetic VectorsHumansBothrops jararaca VenomCrotalid VenomsDisintegrinsRecombinant Proteinsendothelial cellsJararhagin-Crecombinant proteinsnake venom disintegrins

Identifiers

PMID39728782
PMCPMC11728617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.